ARCHIVES

DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards

This article is from The Cancer Letter archive.

Vol. 08 No. 43 | November 5, 1982

Download PDF Visit The Full Archive

Related Articles

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

August 12, 2011

Grassley Pledges More Congressional Oversight of CME.

March 14, 2008

Scientists Brief Writers On Progress In Cancer Research

April 11, 1975

In Brief: Appropriations Hearings Scheduled; Zubro Heads AACI, Nelson Elected ACCC President

February 10, 1978

Breast Cancer Task Force Reorganized, Foiled By Snow

March 2, 1979

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011